AGP Executive Report
Last update: 9 hours agoFTC & Pharma M&A: Aurobindo Pharma USA won US FTC approval to buy Lannett for $250M, aiming to expand complex generics and add Seymour, Indiana capacity for nearly 4B doses annually. Precision Cancer Coverage: Malaysia’s first reinsurance framework for Cancer Precision Medicine (including CAR-T and targeted therapies) is set to help insurers and takaful operators cover advanced cancer care, with overseas treatment benefits in China. Clinical Trial Push: Recce Pharmaceuticals gained ethics approval to move its RECCE® 327 topical gel for diabetic foot infections into pivotal Phase 3, widening eligibility to moderate cases. Healthcare Data & Privacy: Karnataka plans a statewide digital patient record system using consented, OTP-verified access, linking Samasta with ABDM-compliant hospital systems. Public Health & Safety: Sri Lanka’s doctors’ union alleges substandard medical devices are harming patients, calling for a CID probe after withdrawals of stents, catheters and colostomy bags. Care Access & Infrastructure: Kakamega County launched a second renal unit at Butere County Hospital with six dialysis stations to cut travel and expand life-saving haemodialysis. System Stress & Workforce: CoxHealth says 53 revenue-cycle roles were shifted or cut as coding automation took over manual work. Mental Health & Equity: Ghana marks World Sickle Cell Day with calls for urgent mental health support and comprehensive care beyond pain crises. Extreme Heat Watch: UK health agencies issue alerts as record temperatures threaten health and even ear safety.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.